Indications
1% ophthalmic preparation: As a cycloplegic or mydriatic for refraction or for desired dilatation of the iris or uveal tract during acute infammatory conditions.
0.01% ophthalmic preparation: This medication is indicated as a treatment to slow the progression of myopia in children aged from 4 to 14 years. Atropine Sulfate treatment may be initiated in children when myopia progresses.
Dosage And Administration
1% ophthalmic preparation-
For uveitis: One drop three times daily
For refraction: One drop in the eyes twice daily for one or two days before examination, and one hour before examination. Pressure should be maintained over lacrimal sac, occluding lacrimal duct for one minute after instillation.
0.01% ophthalmic preparation- This paediatric eye drops should be administered as one drop to each eye at night. The maximum benefit of treatment may not be achieved with less than a 2-year continued administration period. To minimize the risk of systemic absorption, gentle pressure should be applied to the tear duct for one minute after application.
Side Effects
Blurred vision, local irritation, follicular conjunctivitis, vascular congestion, oedema, exudate, contact dermatitis, eczematous dermatitis, photophobia etc.
Precautions And Warnings
Atropine Sulfate should not be used in children who have previously had severe systemic reaction to Atropine Sulfate. An increased susceptibility to Atropine Sulfate has been reported in children with Down’s syndrome, spastic paralysis, or brain damage; therefore Atropine Sulfate should be used with great caution in these patients. It is recommended that regular eye health clinical reviews are conducted if long term treatment is planned, including the monitoring of anterior segment development, IOP, retinal health and myopia progression. This eye drops should not be used in children less than 4 years of age.
Pregnancy And Lactation
Atropine Sulphate may be systemically absorbed after ocular administration; however, signifcant efects on the fetus have not been reported. Systemically absorbed Atropine Sulphate is distributed into breast milk in very small amounts. It may cause adverse efects, such as rapid pulse, fever, or dry skin, in nursing infant of mothers using ophthalmic Atropine.